TSE:4886Pharmaceuticals
Aska Pharmaceutical (TSE:4886) One Off Gain Clouds Earnings Quality Narrative
ASKA Pharmaceutical HoldingsLtd (TSE:4886) has wrapped up FY 2026 with fourth quarter revenue of ¥16.6 billion and basic EPS of ¥53.53, on trailing 12 month revenue of ¥71.1 billion and EPS of ¥191.10. Over recent quarters, the company has seen revenue move between ¥15.9 billion and ¥19.3 billion, while quarterly EPS ranged from ¥34.60 to ¥59.10. This gives investors a clear view of how the top line and per share earnings have tracked through the year. With a trailing net profit margin of...